Anthropic CEO's wife, Cami Clark, exposed as a key "shadow advisor" to the company, having introduced Eric Schmidt and solicited funds from Epstein.
Cami Clark, wife of Anthropic CEO Dario Amodei, reportedly serves as a key strategic advisor to the company without holding a formal position, and is said to have brought former Google CEO Eric Schmidt into the early investor group. As Anthropic prepares for an IPO with a valuation exceeding $2 trillion, Clark's role is under scrutiny, and her past experiences have been disclosed, including seeking investment from sex offender Jeffrey Epstein for her adult film company. She is currently also involved in Anthropic's political public relations.
Source:华尔街见闻 · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
SpaceX Passes First Lockup Expiry Test With $500 Billion Rally, Easing Wall Street's Concerns Over Potential Flood of Shares After Aug. 6 Expiry
-
2
US tech giants issue massive debt to fund AI, unexpectedly pushing up credit risk for "safest companies" with no AI connection
-
3
South Korean court reportedly sentences Delio CEO Jeong Sang-ho to 15 years in prison for defrauding customers of approximately $49.2 million in crypto assets
-
4
Brazil's largest Bitcoin treasury firm OranjeBTC plans Digital Yield ETF (DIGY11) with 95% allocation to Strategy's STRC
-
5
SK Hynix is investing $720 billion in South Korea to build the world's largest network of memory factories, aiming to meet surging AI demand.
-
6
US government debt nears $40 trillion, with this year's deficit projected at $1.887 trillion and interest payments expected to hit $1.1 trillion.
-
7
US Mortgage Rates Mixed on August 13: 30-Year Fixed Falls to 6.58%, 5/1 ARM Drops to 6.31% Amid Continued Volatility
-
8
China's memory chip giant CXMT surpasses Tencent in market value, becoming the highest market cap company in China's A+H share market.
-
9
Latigo Biotherapeutics (LTGO) completes IPO, raising nearly $350 million, with its non-opioid pain drug LTG-001 showing 50% greater relief than hydrocodone in trials.
-
10
Golar LNG signs $2.45bn EPC agreement for fourth FLNG vessel, targeting 3.5mtpa capacity by late 2029
Markets Today
Recommended Reading


